BACKGROUND The levonorgestrel-releasing IUD can help the treatment of dysmenorrhea by reducing the synthesis of endometrial prostaglandins as a conventional treatment. OBJECTIVE This study was performed to assess the frequency of dysmenorrhea, satisfaction and quality of life in women using Mirena IUDs as compared to those using copper IUDs. MATERIALS AND METHODS This double-blind randomize...

We evaluated the multiyear contraceptive efficacy of the gonadotrophin-releasing hormone (GnRH) vaccine GonaCon, the porcine zona pellucida (PZP) vaccine SpayVac and the human intrauterine device (IUD) 380 Copper ‘T’ in mustang mares provided by the State of Nevada. Eight untreated control mares were compared with 12 mares treated with SpayVac, 16 mares treated with GonaCon and 15 mares treated...

failed. Many colleagues have tried this method and they have had success with it also. I had correspondence from the French company that unless the article were to be endorsed by a professor or senior consultant/colleague in family planning then they were not prepared to change the design. The Ortho Gynae T 380® was discontinued, however it has been adopted for use by other manufacturers with o...

background intrauterine device (iud) is a safe and efficient method for preventing pregnancy favored by many women. menorrhagia is the most common complication of using copper iud. we aimed to compare the effect of tranexamic acid and mefenamic acid on the reduction of copper iud-induced menorrhagia. methods in this randomized controlled trial, 84 women who were using iud (tcu-380) with complai...

Background: Vulvovaginal Candidiasis is one of the most common vaginal infections and identification of candida species can be helpful in medical treatment. Intra uterine devices (IUDs) are effective, long-term methods of contraception, which in some cases may lead to Vulvovaginal Candidiasis. This study was developed to assess the effect of IUD insertion on Candida fungal flora in cervicovagin...

Few studies have compared side effects and removal rates of copper and hormonal intrauterine devices (IUDs). We have recently completed a randomised controlled trial of the levonorgestrel intrauterine system (IUS) (Mirena®, Schering, Germany) and the Copper 380® A (IUD) (India) in 160 Muslim women aged 20–35 years attending the Ayat Health Centre in Iran. Women who presented requesting an IUD f...